Skip to content

Drug interactions

Estrogens conjugated synthetic + Nilotinib

Severity: Minor

Estrogens conjugated synthetic and Nilotinib: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Nilotinib inhibits CYP3A4 and P-glycoprotein, which may raise systemic exposure to synthetic conjugated estrogens. Higher estrogen levels could increase estrogen-related adverse effects such as breast tenderness, fluid retention and thromboembolic risk. The clinical impact is expected to be modest.

What this interaction means in plain words

Estrogens conjugated synthetic and Nilotinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Nilotinib weakly inhibits CYP3A4 and P-glycoprotein, reducing estrogen clearance and efflux.

What to do

Monitor for estrogenic adverse effects such as edema, breast tenderness or bleeding changes. Reduce the estrogen dose if symptoms appear.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Estrogens conjugated synthetic and Nilotinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Estrogens conjugated synthetic with Nilotinib?

MediHelp rates the interaction as minor. Estrogens conjugated synthetic and Nilotinib have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Nilotinib inhibits CYP3A4 and P-glycoprotein, which may raise systemic exposure to synthetic conjugated estrogens. Higher estrogen levels could increase estrogen-related adverse effects such as breast tenderness, fluid retention and thromboembolic risk. The clinical impact is expected to be modest.

How serious is the interaction between Estrogens conjugated synthetic and Nilotinib?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for estrogenic adverse effects such as edema, breast tenderness or bleeding changes. Reduce the estrogen dose if symptoms appear.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in